Antimicrobial and Cytotoxic Activity of Extracts of Ferula heuffelii Griseb. ex Heuff. and Its Metabolites. 2015

Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
University of Belgrade -  Faculty of Pharmacy, Department of Pharmacognosy, Vojvode Stepe 450, RS-11221 Belgrade, (phone: +381-11-3951322; fax: +381-11-3972840).

The antimicrobial and cytotoxic activities of isolates (CHCl3 and MeOH extracts and selected metabolites) obtained from the underground parts of the Balkan endemic plant Ferula heuffelii Griseb. ex Heuff. were assessed. The CHCl3 and MeOH extracts exhibited moderate antimicrobial activity, being more pronounced against Gram-positive than Gram-negative bacteria, especially against Staphylococcus aureus (MIC=12.5 μg/ml for both extracts) and Micrococcus luteus (MIC=50 and 12.5 μg/ml, resp.). Among the tested metabolites, (6E)-1-(2,4-dihydroxyphenyl)-3,7,11-trimethyl-3-vinyldodeca-6,10-dien-1-one (2) and (2S*,3R*)-2-[(3E)-4,8-dimethylnona-3,7-dien-1-yl]-2,3-dihydro-7-hydroxy-2,3-dimethylfuro[3,2-c]coumarin (4) demonstrated the best antimicrobial activity. Compounds 2 and 4 both strongly inhibited the growth of M. luteus (MIC=11.2 and 5.2 μM, resp.) and Staphylococcus epidermidis (MIC=22.5 and 10.5 μM, resp.) and compound 2 additionally also the growth of Bacillus subtilis (MIC=11.2 μM). The cytotoxic activity of the isolates was tested against three human cancer cell lines, viz., cervical adenocarcinoma (HeLa), chronic myelogenous leukemia (K562), and breast cancer (MCF-7) cells. The CHCl3 extract exhibited strong cytotoxic activity against all cell lines (IC50 <11.0 μg/ml). All compounds strongly inhibited the growth of the K562 and HeLa cell lines. Compound 4 exhibited also a strong activity against the MCF-7 cell line, comparable to that of cisplatin (IC50 =22.32±1.32 vs. 18.67±0.75μM).

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005309 Ferula A plant genus of the family APIACEAE. It contains pungent oils and resins. It is used to flavor curries, as a carminative, and as cat and dog repellent. The occasionally used common name of 'giant fennel' should not be confused with true fennel (FOENICULUM). Asafoetida,Asa-foetida,Asafetida,Ferula foetida,Ferula harmonis,Ferula hermonis,Zallouh,Asa foetida,Asa-foetidas,Asafetidas,Asafoetidas,Ferula foetidas,Ferula harmoni,Ferula hermoni,Ferulas,Zallouhs,foetida, Ferula,harmonis, Ferula,hermonis, Ferula
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
May 2023, International journal of molecular sciences,
Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
January 2023, Frontiers in pharmacology,
Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
May 2023, Scientific reports,
Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
December 2023, International journal of molecular sciences,
Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
January 2018, Avicenna journal of phytomedicine,
Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
January 2013, EXCLI journal,
Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
March 2022, Ultrasonics sonochemistry,
Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
December 2021, Natural product research,
Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
March 2012, Molecules (Basel, Switzerland),
Ivan Pavlović, and Silvana Petrović, and Marina Milenković, and Tatjana Stanojković, and Dejan Nikolić, and Aleksej Krunić, and Marjan Niketić
September 1989, Immunology letters,
Copied contents to your clipboard!